
无数据
无数据
无数据
| CAS Number | 87-89-8 |
| Catalog Number | AG00IEB4(AGN-PC-0VHI0P) |
| Chemical Name | myo-Inositol |
| IUPAC Name | cyclohexane-1,2,3,4,5,6-hexol |
| InChI | InChI=1S/C6H12O6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-12H |
| InChI Key | CDAISMWEOUEBRE-UHFFFAOYSA-N |
| MDL Number | MFCD00077932 |
| Molecular Formula | C6H12O6 |
| Molecular Weight | 180.1559 |
| SMILES | O[C@H]1[C@H]([C@H]([C@@H]([C@H]([C@@H]1O)O)O)O)O |
| Synonyms | (1R,2R,3R,4R,5R,6R)-1,2,3,4,5,6-cyclohexanehexol,
AZD-103,
ELND005,
quercinitol,
scyllitol,
scyllo-inositol,
inositol,
myo-inositol,
Scyllo-inositol,
Muco-Inositol,
epi-Inositol,
i-Inositol,
Allo-inositol,
meso-Inositol,
87-89-8,
1D-Chiro-inositol,
1L-Chiro-inositol,
Myoinositol,
488-59-5,
Scyllitol,
643-12-9,
D-(+)-chiro-Inositol,
cis-Inositol,
mesoinositol,
Myoinosite,
Quercinitol,
Dambose,
Cyclohexane-1,2,3,4,5,6-hexaol,
Neo-inositol,
6917-35-7,
Meat sugar,
Cocositol,
D-chiro-Inositol,
Inositene,
Inositina,
Phaseomannite,
Inosital,
Iso-inositol,
cyclohexane-1,2,3,4,5,6-hexol,
Cyclohexitol,
Phaseomannitol,
Mesoinosit,
Mesoinosite,
Scyllite,
Inosite,
Mesovit,
Nucite,
Mesol,
551-72-4,
L-chiro-Inositol,
488-58-4,
chiro-inositol,
Cyclohexanehexol,
Inositol, meso-,
Inositol, myo-,
D-myo-Inositol,
Bios I,
Insitolum,
Isoinositol,
(-)-Inositol,
643-10-7,
cis-1,2,3,5-trans-4,6-Cyclohexanehexol,
Hexahydroxycyclohexane,
41546-34-3,
L-Inositol,
L-myo-Inositol,
Inositol, i-,
Inositol (VAN),
D-chiro Inositol,
Inositol, allo-,
Inositol, muco-,
1D-myo-Inositol,
1L-myo-Inositol,
488-55-1,
(+)-Inositol,
1,2,3,4,5,6-Cyclohexanehexol,
Rat antispectacled eye factor,
Levoinositol,
CCRIS 6745,
L-(-)-chiro-Inositol,
Mouse antialopecia factor,
AZD 103,
Inositol, epi-,
Inositol, scyllo-,
UNII-63GQX5QW03,
UNII-8LQ63P85IC,
UNII-9O6Y5O4P9W,
UNII-R1Y9F3N15A,
1,2,3,5-trans-4,6-Cyclohexanehexol, cis-,
MFCD00077932,
(1r,2r,3r,4r,5r,6r)-cyclohexane-1,2,3,4,5,6-hexol,
1,3,5/2,4,6-Hexahydroxycyclohexane,
UNII-4661D3JP8D,
UNII-6R79WV4R10,
(1R,2R,3R,4R,5S,6S)-Cyclohexane-1,2,3,4,5,6-hexaol,
(1R,2R,3S,4S,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol,
1-L-chiro-Inositol,
(-)-chiro-Inositol,
576-63-6,
UNII-1VS4X81277,
CHEBI:17268,
AI3-16111,
NSC8101,
1,3,5/2,4,6-cyclohexanehexol,
UNII-4L6452S749,
UNII-587A93P465,
1,2,3,5/4,6-Cyclohexanehexol,
NSC 8101,
EINECS 201-781-2,
(1R,2R,3R,4S,5S,6s)-cyclohexane-1,2,3,4,5,6-hexaol,
(1R,2R,3S,4R,5r,6S)-cyclohexane-1,2,3,4,5,6-hexaol,
(1R,2R,3S,4S,5S,6S)-Cyclohexane-1,2,3,4,5,6-hexaol,
1,2,3,4,5,6-HEXAHYDROXY-CYCLOHEXANE,
MFCD00065455,
NSC404118,
Inositol, myo- (8CI),
488-54-0,
1,2,3,4,5,6-Hexahydroxycyclohexane,
NSC 404118,
63GQX5QW03,
8LQ63P85IC,
9O6Y5O4P9W,
R1Y9F3N15A,
MI,
myo -Inositol,
CHEBI:10642,
CHEBI:23927,
CHEBI:27372,
CHEBI:27987,
CDAISMWEOUEBRE-CDRYSYESSA-N,
CDAISMWEOUEBRE-UHFFFAOYSA-N,
4661D3JP8D,
6R79WV4R10,
Inositol (VAN8C,
NSC45517,
NSC55551,
NSC55552,
UNII-M94176HJ2F,
1VS4X81277,
INS,
Inositol, 98+%,
(1s,2s,3s,4s,5s,6s)-cyclohexane-1,2,3,4,5,6-hexol,
NCGC00159409-02,
(1r,2R,3S,4s,5R,6S)-cyclohexane-1,2,3,4,5,6-hexol,
(1s,2R,3R,4s,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol,
4L6452S749,
587A93P465,
DSSTox_CID_3146,
DSSTox_RID_76890,
DSSTox_GSID_23146,
38876-99-2,
1,3,4,5,6-Cyclohexanehexol,
1,3,5/4,6-Cyclohexanehexol,
alloinositol,
neoinositol,
(1R,2R,3R,4R,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol,
(1r,2R,3R,4s,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol,
(1r,2R,3S,4r,5R,6S)-cyclohexane-1,2,3,4,5,6-hexol,
1,2,4/3,5,6-cyclohexanehexol,
MFCD00272608,
1,2,3,4,5,6-Cyclohexanehexol #,
Inositol, cis-,
Inositol, neo-,
CAS-87-89-8,
cis-1,3,5-trans-4,6-Cyclohexanehexol,
SMR000857145,
SMR000857319,
SMR000857320,
M94176HJ2F,
Inositol NF 12,
1,2,3,4,5,6-cyclohexanhexol,
SR-05000001655,
Chiro-inositol, (-)-,
inositols,
Matezodambose,
ELND005,
Inositol [Nonspecific isomer],
Muscle sugar,
Myo inositol,
ELND 005,
inositol myo-,
Inositol FCC,
4irx,
Inositol, chiro-,
Inosital (TN),
CBU,
epi-Cyclohexanehexol,
Inositol (USAN),
EINECS 207-681-5,
EINECS 207-682-0,
EINECS 209-000-7,
EINECS 211-393-5,
EINECS 211-394-0,
EINECS 230-024-9,
NSC 25142,
EPIINOSITOL,
(+)-Epi-Inositol,
(+)-Chiro-Inositol,
scyllo-Cyclohexanehexol,
Epi-inositol, 98%,
allo-Inositol, 97%,
Inositol [USAN:NF],
INOSITOL, MESO,
Spectrum_001595,
2os9,
D-(+)-Chiro Inositol,
J101.890F,
J101.891D,
AC1Q2AJJ,
Chiro-inositol, (+)-,
INOSITOL (D),
INOSITOL (L),
Spectrum3_001053,
Spectrum4_001193,
Spectrum5_000961,
myo-Inositol, >=99%,
bmse000102,
bmse000103,
bmse000113,
bmse000901,
bmse000922,
Epitope ID:144993,
scyllo-Inositol, >=98%,
AC1L1A9E,
SCHEMBL5831,
SCHEMBL5832,
SCHEMBL5969,
NCIOpen2_008191,
BSPBio_002606,
KBioGR_001885,
KBioSS_002075,
KSC225S4P,
MLS001332377,
MLS001332378,
MLS001335965,
MLS001335966,
MLS001335967,
MLS001335968,
SCHEMBL187278,
SCHEMBL187397,
SCHEMBL187796,
SCHEMBL188106,
SCHEMBL188237,
SCHEMBL491333,
SCHEMBL959404,
SCHEMBL959405,
CHEMBL122705,
CHEMBL278373,
CHEMBL468154,
GTPL4495,
GTPL4645,
GTPL4648,
GTPL4649,
MEGxp0_001817,
SCHEMBL1055883,
SCHEMBL4748543,
SCHEMBL6378921,
SCHEMBL6468882,
SCHEMBL6791918,
CHEMBL1222251,
CHEMBL1231671,
CHEMBL1950780,
CHEMBL3976780,
SCHEMBL12371461,
SCHEMBL12377889,
SCHEMBL12411898,
SCHEMBL12711208,
SCHEMBL12735687,
SCHEMBL13058696,
SCHEMBL13114115,
SCHEMBL13114116,
SCHEMBL13114128,
SCHEMBL13207905,
SCHEMBL13580047,
SCHEMBL14542470,
ACon1_002457,
CHEBI:22357,
CHEBI:23311,
CHEBI:24848,
CHEBI:25492,
CHEBI:27374,
CTK1C5947,
CTK8B3795,
D-(+)-chiro-Inositol, 95%,
KBio2_002075,
KBio2_004643,
KBio2_007211,
KBio3_001826,
L-(-)-chiro-Inositol, 95%,
myo-Inositol, p.a., 98.0%,
CDAISMWEOUEBRE-GNIYUCBRSA-N,
CDAISMWEOUEBRE-GPIVLXJGSA-N,
CDAISMWEOUEBRE-LOLGQZEGSA-N,
CDAISMWEOUEBRE-NIPYSYMMSA-N,
CDAISMWEOUEBRE-OQYPVSDDSA-N,
1,2,3,4,5/6-cyclohexanehexol,
1,2,3,4/5,6-cyclohexanehexol,
1,2,3/4,5,6-cyclohexanehexol,
1,2,4,5/3,6-cyclohexanehexol,
HMS2091N13,
HMS2230N03,
HMS2235H05,
HMS2235M23,
HMS3369B06,
HMS3369F20,
HMS3373E05,
Pharmakon1600-01500352,
(1/4) inverted exclamation markIC,
1,2,3,4,5,6-Cyclohexanehexaol,
BCP25172,
HY-B1411,
KS-00000QA9,
KS-000017FC,
NSC-8101,
NSC25142,
NSC55558,
ZINC1530357,
D-myo-Inositol, Cell Culture Grade,
Tox21_111642,
Tox21_302035,
6643AB,
ANW-43204,
CC-093,
CCG-36096,
cis-Inositol, >=98.0% (TLC),
KM0846,
MFCD00003863,
MFCD00799555,
MFCD00799556,
MFCD01321249,
NSC-25142,
NSC-45517,
NSC-55551,
NSC-55552,
NSC-55558,
NSC103959,
NSC127230,
NSC757076,
s4530,
STL453612,
epi-Inositol, >=98.0% (HPLC),
1,2,3,4,5,6/0-cyclohexanetetrol,
AKOS006240678,
AKOS006332036,
AKOS015895894,
AKOS015912905,
AKOS015912934,
AKOS015960429,
AKOS015960633,
AKOS015994742,
AKOS024318869,
AKOS027320475,
AKOS027327401,
Tox21_111642_1,
ZINC100018867,
ZINC100019018,
ZINC100024490,
ZINC100032893,
ZINC100035580,
ZINC100037751,
ZINC100055570,
ZINC100073149,
ZINC100513675,
ZINC101185827,
ZINC102201844,
ZINC103574430,
ZINC103574467,
ZINC103574475,
ZINC250615063,
ZINC253837650,
ZINC306121118,
1,2,4/3,5,6-Hexahydroxycyclohexane,
CS-4782,
DB03106,
DB13178,
FCH1118762,
KS-1284,
KS-1420,
LS-2350,
MCULE-2727773046,
NSC-103959,
NSC-127230,
NSC-404118,
NSC-757076,
RP24128,
TRA0065469,
VC30505,
KS-0000146H,
TRA-0204644,
D-chiro-Inositol, >=98.0% (HPLC),
NCGC00159409-03,
NCGC00159409-04,
NCGC00169828-01,
NCGC00178580-01,
NCGC00178580-03,
NCGC00255362-01,
AC-11070,
AJ-26654,
AK102790,
AK546883,
AN-18118,
AN-23658,
AN-24133,
AS-10616,
CJ-05199,
CJ-23964,
cyclohexane-1R,2R,3S,4S,5R,6S-hexol,
K572,
NCI60_041778,
SC-18136,
SC-91157,
SY060836,
myo-Inositol, purum, >=98.0% (HPLC),
SBI-0051369.P003,
AB0014290,
AX8234329,
cis-1,2,4-trans-3,5,6-Cyclohexanehexol,
myo-Inositol, for microbiology, >=99.0%,
TL8004550,
TL8004551,
TR-016439,
TR-017741,
TR-019452,
TR-022051,
TR-022053,
4CH-024633,
FT-0627237,
FT-0632208,
FT-0632209,
FT-0632730,
FT-0652045,
FT-0670357,
FT-0693444,
FT-0693614,
I0040,
I0628,
I0629,
I0630,
I0631,
I0632,
I0633,
ST24024704,
ST24049158,
ST50406013,
KS-00001292,
KS-00001315,
MFCD00077932 (97%),
myo-Inositol, BioUltra, >=99.5% (HPLC),
myo-Inositol, SAJ special grade, >=99.0%,
myo-Inositol, Vetec(TM) reagent grade, 99%,
(1R)-Cyclohexane-1r,2c,3t,4c,5t,6t-hexaol,
3635-EP2275412A1,
3635-EP2280282A1,
3635-EP2289886A1,
3635-EP2292088A1,
3635-EP2295417A1,
3635-EP2295437A1,
3635-EP2298312A1,
3635-EP2298775A1,
3635-EP2305636A1,
3635-EP2305677A1,
3635-EP2305682A1,
3635-EP2308879A1,
C00137,
C06151,
C06152,
C06153,
C19891,
D08079,
I-6500,
K-9876,
M01914,
meso-(1/4) inverted exclamation mark (1/4),
12513-EP2277880A1,
12513-EP2277881A1,
12513-EP2292597A1,
12513-EP2292610A1,
12513-EP2298744A2,
12513-EP2298768A1,
12513-EP2305825A1,
12513-EP2316831A1,
12513-EP2374790A1,
13719-EP2269977A2,
13719-EP2280010A2,
13719-EP2289891A2,
13719-EP2295437A1,
13719-EP2298734A2,
13719-EP2298775A1,
13719-EP2308875A1,
13719-EP2311831A1,
13719-EP2316836A1,
40032-EP2298312A1,
40032-EP2311830A1,
AB00051982_13,
643C129,
A834712,
A836375,
I06-1350,
I14-2742,
Q-201583,
Scyllite (for the structural isomer scyllo-Inositol),
SR-05000001655-1,
SR-05000001655-5,
W-202861,
W-202862,
W-203081,
W-203168,
W-203392,
1,2,4/3,5,6-Cyclohexane-1,2,3,4,5,6-hexol,
7B0CEF84-D9CE-4A88-AA7D-EC50C89387A5,
I14-47229,
I14-47230,
I14-47231,
I14-47232,
I14-60538,
1D7A27BF-6060-4FA9-AC46-3BD18DBA406E,
220128F1-89BF-442D-AD6D-E6D1EA7BA625,
I14-101844,
(1r,2r,3r,4r,5r,6r)-cyclohexane-1,2,3,4,5,6-hexaol,
(1R,2S,3r,4R,5S,6s)-cyclohexane-1,2,3,4,5,6-hexol,
(1R,2S,3S,4R,5S,6r)-cyclohexane-1,2,3,4,5,6-hexol,
D-MYO-INOSITOL-1,2,5,6-TETRAPHOSPHATE SODIUM SALT,
UNII-M94176HJ2F component CDAISMWEOUEBRE-LKPKBOIGSA-N,
UNII-M94176HJ2F component CDAISMWEOUEBRE-SHFUYGGZSA-N,
(1R,2R,3S,4R,5S,6S)-cyclohexane-1,2,3,4,5,6-hexaol,
(1R,2R,3S,4R,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol,
Inositol, United States Pharmacopeia (USP) Reference Standard,
myo-Inositol, European Pharmacopoeia (EP) Reference Standard,
1,2,3,4,5,6-Cyclohexanehexol, (cis,cis,cis,trans,cis,trans)- #,
1,2,3,4,5,6-cyclohexanehexol, (1alpha,2alpha,3alpha,4beta,5alpha,6beta),
Inositol, Pharmaceutical Secondary Standard; Certified Reference Material,
2H3,
myo-Inositol, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture,
myo-Inositol, PharmaGrade, meets FCC testing specifications, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production.,
d-Inositol,
nitrofurazone,
Pinitol,
scyllo inositol,
Mio-inositol,
Chiro Inositol,
Myo- inositol,
Hexahydroxybenzene,
Vitamin B8,
Inositol [NF],
DTLET,
Inositol, D-chiro-,
Inositol, L-chiro-,
D-( )-chiro-Inositol,
D03SHD,
D07CPO,
D08DXZ,
D0B1EY,
D0Y4UQ,
D- -CHIRO-INOSITOL,
myo-Inositol, 98% 100g,
C6H12O6,
CID892,
AXD 103,
KST-1B9360,
Scyllo-Inositol, 98% - 1G 1g,
AR-1B5044,
C6-H12-O6,
>>.(1/4) masculineAu (1/4),
CS-O-30601,
CS-T-29378,
Meso-Inositol 99% for biochemistry 25gm,
A16010,
D-( )-chiro-Inositol, 98% - 100MG 100mg,
D007294,
DCI,
938-87-4,
1067-71-6,
106778-42-1,
173524-45-3,
|
| Complexity | 104 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 180.063g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 12 |
| Hydrogen Bond Acceptor Count | 6 |
| Hydrogen Bond Donor Count | 6 |
| Isotope Atom Count | 0 |
| Molecular Weight | 180.156g/mol |
| Monoisotopic Mass | 180.063g/mol |
| Rotatable Bond Count | 0 |
| Topological Polar Surface Area | 121A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -3.7 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

